venlafaxine hydrochloride has been researched along with Polyneuropathies in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bach, FW; Demant, D; Finnerup, NB; Holbech, J; Jensen, TS; Sindrup, SH | 1 |
Ehler, E; Meleková, A | 1 |
Bach, FW; Gram, LF; Jensen, TS; Madsen, C; Sindrup, SH | 1 |
Bach, FW; Jensen, TS; Otto, M; Sindrup, SH | 1 |
3 trial(s) available for venlafaxine hydrochloride and Polyneuropathies
Article | Year |
---|---|
Impact of etiology and duration of pain on pharmacological treatment effects in painful polyneuropathy.
Topics: Adult; Aged; Anticonvulsants; Antidepressive Agents; Carbamazepine; Diabetic Neuropathies; Female; Humans; Imipramine; Male; Middle Aged; Neuralgia; Oxcarbazepine; Polyneuropathies; Pregabalin; Retrospective Studies; Time Factors; Venlafaxine Hydrochloride | 2017 |
Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial.
Topics: Adult; Aged; Analgesics, Non-Narcotic; Cross-Over Studies; Cyclohexanols; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Neuralgia; Neurotransmitter Uptake Inhibitors; Norepinephrine; Pain Measurement; Polyneuropathies; Pressure; Serotonin; Touch; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Health-related quality of life and its predictive role for analgesic effect in patients with painful polyneuropathy.
Topics: Adult; Aged; Aged, 80 and over; Analgesia; Analgesics; Cross-Over Studies; Cyclohexanols; Drug Resistance; Female; Health Status; Humans; Hypericum; Male; Middle Aged; Pain Measurement; Pain Threshold; Pain, Intractable; Placebos; Polyneuropathies; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Valproic Acid; Venlafaxine Hydrochloride | 2007 |
1 other study(ies) available for venlafaxine hydrochloride and Polyneuropathies
Article | Year |
---|---|
Neuromyotonia with polyneuropathy, prominent psychoorganic syndrome, insomnia, and suicidal behavior without antibodies: a case report.
Topics: Adrenergic alpha-Antagonists; Aged; Antidepressive Agents, Second-Generation; Electromyography; Humans; Immunoglobulins, Intravenous; Isaacs Syndrome; Male; Mianserin; Mirtazapine; Polyneuropathies; Sleep Initiation and Maintenance Disorders; Suicide, Attempted; Venlafaxine Hydrochloride | 2015 |